Kejia Li

Kejia Li

Auto-generated profile, based on publicly available information

Kejia Li

Molecular Systems Biology unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2025 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
KLKejia Li
Kejia Li
CPClement M. Potel
Clement M. Potel
IBIsabelle Becher
Isabelle Becher
NHNico Hüttmann
Nico Hüttmann
MGMartin Garrido-Rodriguez
Martin Garrido-Rodriguez
MSMikhail M. Savitski
Mikhail M. Savitski
Systematic mapping of protein–ligand interactions is essential for understanding biological processes and drug mechanisms. Peptide-centric local stability assay (PELSA) is a powerful tool for detecting these interactions and identifying potential binding sites. However, its original workflow is limited in throughput, sample compatibility and accessible protein targets. Here, we introduce a high-throughput adaptation—HT-PELSA—that increases sample processing efficiency by 100-fold while maintaining high sensitivity and reproducibility. HT-PELSA substantially extends the capabilities of the original method by enabling sensitive protein–ligand profiling in crude cell, tissue and bacterial lysates, allowing the identification of membrane protein targets in diverse biological systems. We demonstrate that HT-PELSA can precisely and accurately determine binding affinities of small molecule inhibitors, sensitively detect direct and allosteric ATP binding sites, and reveal off-target interactions of a marketed kinase inhibitor in heart tissue. By enhancing scalability, reducing costs and enabling system-wide drug screening across a wide range of sample types, HT-PELSA—when combined with next-generation mass spectrometry—may offer a powerful platform poised to accelerate both drug discovery and basic biological research.

29 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
KLKejia Li
Kejia Li
CPClement M Potel
Clement M Potel
IBIsabelle Becher
Isabelle Becher
NHNico Hüttmann
Nico Hüttmann
MGMartin Garrido-Rodriguez
Martin Garrido-Rodriguez
MSMikhail M Savitski
Mikhail M Savitski
Systematic mapping of protein-ligand interactions is essential for understanding biological processes and drug mechanisms. Peptide-centric local stability assay (PELSA) is a powerful tool for detecting these interactions and localizing potential binding sites. However, its original workflow is limited in throughput, sample compatibility and accessible protein targets. Here, we introduce a high-throughput adaptation - HT-PELSA - that increases sample processing efficiency 100-fold while maintaining high sensitivity and reproducibility. HT-PELSA substantially extends the capabilities of the original method by enabling sensitive protein-ligand profiling in crude cell, tissue and bacterial lysates, making it possible to identify membrane protein targets in diverse biological systems. We demonstrate that HT-PELSA can precisely and accurately determine binding affinities of small molecule inhibitors, sensitively detect direct and allosteric ATP binding, and reveal off-target interactions of a marketed kinase inhibitor in heart tissue. By enhancing scalability, reducing costs, and enabling system-wide drug screening across a wide range of sample types, HT-PELSA - when combined with next-generation mass spectrometry - offers a powerful platform poised to accelerate both drug discovery and basic biological research.

21 October 2026 in Nature Communications
Verified
Journal Article
Open access
YLYanan Li
Yanan Li
DYDi Yu
Di Yu
HZHaiyang Zhu
Haiyang Zhu
SMSijie Mei
Sijie Mei
YWYan Wang
Yan Wang
HWHailin Wang
Hailin Wang

4 July 2025 in Research Square
Verified
Preprint
Open access
PDF file
HWHailin Wang
Hailin Wang
YLYanan Li
Yanan Li
DYDi Yu
Di Yu
HZHaiyang Zhu
Haiyang Zhu
SMSijie Mei
Sijie Mei
Mingliang YeMingliang Ye
Mingliang Ye
Current methods for mapping ligand-protein interactions struggle to resolve weak but critical binding events and conformational dynamics, particularly for endogenous hormones with pleiotropic functions like 17β-estradiol (E2). In this study, we developed a two-dimensional (2D) PEptide-centric Local Stability Assay (PELSA). By detecting increasing ligand dose-induced local binding rates in peptide-level, 2D-PELSA allows highly reliable target identification (~ 98% true identification for staurosporine) and systematic readout of ligand-induced multidimensional structural effects (direct interaction, allosteric regulation, complex regulation, etc.), as well as direct measurement of local binding affinities in native cellular environments. We then demonstrated the versatility of 2D-PELSA by investigating the interactions of 17β-estradiol (E2), a predominant sex hormone that exerts a wide spectrum function in both health and disease. As a result, 2D-PELSA totally detected 1134 conformotypic peptides, 112 E2-responsive segments, and 37 candidate targets with weak binding affinities (> μM), which were highly enriched in the process of fatty acid beta-oxidation. Among these proteins, GPX4, a key negative regulator of ferroptosis, was found to interact with E2 with an affinity of 2.0 μM and to be degraded upon E2 treatment at micromolar concentrations. This interaction was further validated by several Western- and MS-based orthogonal methods. Subsequent phenotype characterization and omics analysis indicated that chronic exposure to E2 in the micromolar range indeed facilitated oxidative, iron-dependent ferroptosis through shaping the cellular lipid composition. As an emerging analytical platform, 2D-PELSA is poised to become an important tool for structural biology and mechanism-driven applications in toxicology and drug discovery.